Felbinac
Sold as Dolinac
Every registration of this product has been cancelled.
Background
Registration
- Applicants
- 1
- Registrations
- 1
Applicants and registrations
| Applicant | Brands | Dosages | Registrations | Schedule | Leaflets |
|---|---|---|---|---|---|
| Pharmacare limited û woodmeadCancelled | Dolinac | 30 mg/g | V0154 | Not determined | None |
Variants
| Product | Strength and form | Registration | Status | Schedule | Leaflets |
|---|---|---|---|---|---|
| Dolinac gel 30 mg/g EACH 1 g GEL CONTAINS FELBINAC 30 mg | 30 mg/gGel | V0154V/3.1/154 | Cancelled | Not determined | None |
Regulatory status
This product is still scheduled by law even when this site could not determine which tier it falls under. The label carries the S number in a square border; ask a pharmacist if you need to know its schedule.
Listings for this ingredient that could not be applied to this product
S3: Felbinac
- except when intended for application to the skin.
Consolidated Schedules 06 July 2026, line 3557
S1: Felbinac
- when intended for application to the skin.
Consolidated Schedules 06 July 2026, line 432
This is an informational summary of the Medicines and Related Substances Act 101 of 1965 and its 2017 General Regulations. It is not medical advice and not legal advice. Always check the medicine's label, which carries the schedule number inside a square border, or ask a pharmacist if you are unsure.
SAHPRA documents
SAHPRA has not published a professional information or patient information leaflet for this product.